R. R. Rubin

2.1k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

R. R. Rubin is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Epidemiology. According to data from OpenAlex, R. R. Rubin has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Family Practice and 3 papers in Epidemiology. Recurrent topics in R. R. Rubin's work include Diabetes Management and Research (8 papers), Diabetes Management and Education (7 papers) and Diabetes Treatment and Management (5 papers). R. R. Rubin is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Management and Education (7 papers) and Diabetes Treatment and Management (5 papers). R. R. Rubin collaborates with scholars based in United States, United Kingdom and Netherlands. R. R. Rubin's co-authors include Mark Peyrot, Søren Skovlund, T. Lauritzen, Frank J. Snoek, David R. Matthews, David G. Marrero, Bradley J. Anderson, Edwin B. Fisher, Sara B. Johnson and Daniel J. Cox and has published in prestigious journals such as Diabetes Care, Diabetologia and Appetite.

In The Last Decade

R. R. Rubin

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study

2005 693 citations Mark Peyrot, R. R. Rubin et al. Diabetic Medicine profile →

Peers

Countries citing papers authored by R. R. Rubin

Since Specialization

Citations

This map shows the geographic impact of R. R. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. R. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. R. Rubin more than expected).

Fields of papers citing papers by R. R. Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. R. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. R. Rubin. The network helps show where R. R. Rubin may publish in the future.

Co-authorship network of co-authors of R. R. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of R. R. Rubin. A scholar is included among the top collaborators of R. R. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. R. Rubin. R. R. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Development and validation of the Diabetes Medication System Rating Questionnaire‐Short Form 2014 ·Diabetic Medicine ·Mark Peyrot, Yunfei Xu, R. R. Rubin	12
2	Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study 2013 ·Quality of Life Research ·David G. Marrero, Qing Pan, Elizabeth Barrett‐Connor, Mary de Groot, (unknown), (unknown), Hermes Flórez, Ronald T. Ackermann, Maria G. Montez, R. R. Rubin	32
3	Patient-reported outcomes in the practice-based opportunities for weight reduction (POWER) trial 2013 ·Quality of Life Research ·R. R. Rubin, Mark Peyrot, Nae‐Yuh Wang, Janelle W. Coughlin, Gerald J. Jerome, Stephanie L. Fitzpatrick, Wendy L. Bennett, Arlene Dalcin, Gail L. Daumit, Nowella Durkin, (unknown), Hsin‐Chieh Yeh, Thomas A. Louis, Lawrence J. Appel	22
4	Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP ‐1 analogue versus progression to basal‐bolus therapy 2013 ·Diabetes Obesity and Metabolism ·Irl B. Hirsch, John B. Buse, J.L. Leahy, Janet B. McGill, Anne L. Peters, Helena W. Rodbard, R. R. Rubin, Jay S. Skyler, (unknown), Matthew C. Riddle	8
5	Treatment satisfaction in the Sensor‐Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial 2012 ·Diabetic Medicine ·Mark Peyrot, R. R. Rubin, (unknown)	27
6	Validation of a tool to assess medication treatment satisfaction in patients with Type 2 diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ) 2011 ·Diabetic Medicine ·Mark Peyrot, Qing Harshaw, Alicia C. Shillington, Yunfei Xu, R. R. Rubin	15
7	Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults 2011 ·Diabetologia ·An Pan, Qi Sun, Olivia I. Okereke, Kathryn M. Rexrode, R. R. Rubin, Michel Lucas, Walter C. Willett, JoAnn E. Manson, Frank B. Hu	80
8	Factors associated with physician perceptions of and willingness to recommend inhaled insulin 2010 ·Current Medical Research and Opinion ·R. R. Rubin, Mark Peyrot	10
9	Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes 2010 ·Diabetologia ·R. R. Rubin, Sarah A. Gaussoin, Mark Peyrot, Vicki DiLillo, Kellee M. Miller, Thomas A. Wadden, Delia Smith West, Rena R. Wing, William C. Knowler	42
10	Depression predicts first but not recurrent diabetic foot ulcers 2010 ·Diabetologia ·Jeffrey S. Gonzalez, Loretta Vileikytė, Jan S. Ulbrecht, R. R. Rubin, Adam Garrow, (unknown), P. R. Cavanagh, Andrew J.M. Boulton, Mark Peyrot	68
11	Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily¹ 2009 ·Diabetic Medicine ·Jennie H. Best, Kristina S. Boye, R. R. Rubin, Dachuang Cao, (unknown), Mark Peyrot	84
12	Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study 2009 ·Diabetologia ·Loretta Vileikytė, Mark Peyrot, Jeffrey S. Gonzalez, R. R. Rubin, Adam Garrow, (unknown), Christine Waterman, Jan S. Ulbrecht, P. R. Cavanagh, Andrew J.M. Boulton	90
13	Change in hunger, fullness, ghrelin, PYY and GLP-1 in relation to a fixed test meal pre and post Rou-en-Y gastric bypass (RYGBS). 2007 ·Appetite ·(unknown), R. R. Rubin, Nicholas A. Wright, Louis Flancbaum, Allan Geliebter	3
14	Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study 2006 ·Diabetologia ·(unknown), Mark Peyrot, R. R. Rubin, T. Lauritzen, Søren Skovlund, Frank J. Snoek, David R. Matthews, R. Landgraf	91
15	Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study breakdown → 2005 ·Diabetic Medicine ·Mark Peyrot, R. R. Rubin, T. Lauritzen, Frank J. Snoek, David R. Matthews, Søren Skovlund	693
16	Persistence of depressive symptoms in diabetic adults. 1999 ·Diabetes Care ·Mark Peyrot, R. R. Rubin	126
17	Behavioral science in diabetes. Contributions and opportunities. 1999 ·Diabetes Care ·Russell E. Glasgow, Edwin B. Fisher, Bradley J. Anderson, (unknown), David G. Marrero, Sara B. Johnson, R. R. Rubin, Daniel J. Cox	177
18	Psychotherapy in Diabetes Mellitus. 1997 ·PubMed ·R. R. Rubin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact